Dyadic International/$DYAI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Dyadic International
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Ticker
$DYAI
Sector
Primary listing
Employees
5
Headquarters
Website
DYAI Metrics
BasicAdvanced
$37m
-
-$0.21
1.17
-
Price and volume
Market cap
$37m
Beta
1.17
52-week high
$1.35
52-week low
$0.65
Average daily volume
477k
Financial strength
Current ratio
2.418
Quick ratio
2.078
Long term debt to equity
-1,234.493
Total debt to equity
-1,239.398
Interest coverage (TTM)
-15.64%
Profitability
Gross margin (TTM)
26.10%
Net profit margin (TTM)
-191.50%
Operating margin (TTM)
-185.49%
Revenue per employee (TTM)
$760,000
Management effectiveness
Return on assets (TTM)
-56.22%
Return on equity (TTM)
-2,826.92%
Valuation
Price to revenue (TTM)
9.175
Price to book
-91.16
Price to tangible book (TTM)
-91.16
Price to free cash flow (TTM)
-6.112
Free cash flow yield (TTM)
-16.36%
Free cash flow per share (TTM)
-0.167
Growth
Revenue change (TTM)
7.13%
Earnings per share change (TTM)
8.07%
3-year revenue growth (CAGR)
5.31%
10-year revenue growth (CAGR)
26.45%
3-year earnings per share growth (CAGR)
-9.56%
10-year earnings per share growth (CAGR)
-19.39%
What the Analysts think about DYAI
Analyst ratings (Buy, Hold, Sell) for Dyadic International stock.
DYAI Financial Performance
Revenues and expenses
DYAI Earnings Performance
Company profitability
DYAI News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs